Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
BNB treasury company plunges 77% after Nasdaq delisting notice
Related Posts
Canary’s amended S-1 has analysts more confident a Litecoin ETF is next
Bloomberg ETF analyst Eric Balchunas warned that an imminent change in the SEC leadership could shake things up.
No blockchain can be a ‘lonely island’ — Emurgo exec
Emurgo’s global head of business development, Amarpreet Singh, told Cointelegraph that all roads lead to interoperability.
Hamster Kombat turns down venture capital offers
Hamster Kombat has attracted more than 300 million users to the game, setting records in Web3 game development.
